Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)

CompletedOBSERVATIONAL
Enrollment

708

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

October 24, 2023

Study Completion Date

October 24, 2023

Conditions
COPD
Trial Locations (1)

Unknown

Research Site, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY